雙側子宮內膜異位瘤IVF前施行子宮內膜異位瘤切除手術會影響IVF懷孕率
(手術懷孕率 vs.非手術懷孕率=7% vs. 19% )
http://humrep.oxfordjournals.org/content/23/7/1526.full
IVF–ICSI outcome in women operated on for bilateral endometriomas
- Edgardo Somigliana1,
- Mariangela Arnoldi1,2,
- Laura Benaglia1,2,3,
- Roberta Iemmello1,2,
- Anna Elisa Nicolosi1,2 and
- Guido Ragni1
+Author Affiliations
- 3Correspondence address. Tel: +39-02-55034303; Fax: +39-02-55034302. E-mail:laurabenaglia@hotmail.it
- Received December 18, 2007.
- Revision received February 11, 2008.
- Accepted March 28, 2008.
Abstract
BACKGROUND The influence of previous conservative surgery for endometriomas on IVF–ICSI outcome is debated. Conflicting information emerging from the literature may be consequent to the fact that endometriomas are mostly monolateral. The contralateral intact ovary may adequately supply for the reduced function of the affected one. To clarify this point, we assess IVF–ICSI outcome in women operated on for bilateral endometriomas.
METHODS Women selected for IVF–ICSI cycles who previously underwent bilateral endometriomas cystectomy were matched (1:2) for age and study period with patients who did not undergo prior ovarian surgery.
RESULTS Sixty-eight cases and 136 controls were recruited. Women operated on for bilateral endometriotic ovarian cysts had a higher withdrawal rate for poor response (P < 0.001). In these patients, despite the use of higher doses of gonadotrophins, the number of follicles (P = 0.006), oocytes retrieved (P = 0.024) and embryos obtained (P = 0.024) were significantly lower. The clinical pregnancy rate per started cycle in cases and controls was 7% and 19% (P = 0.037) and the delivery rate per started cycle was 4% and 17%, respectively (P = 0.013).
CONCLUSIONS IVF outcome is significantly impaired in women operated on for bilateral ovarian endometriomas.
IVF–ICSI outcome in women operated on for bilateral endometriomas
Characteristics | Cases (n = 68) | Controls (n = 136) | p |
---|---|---|---|
Cancelled cycle | <0.001 | ||
Hyper-response | 1 (2%) | 20 (15%) | |
Poor response | 17 (28%) | 8 (6%) | |
Dosage of rFSH/die | 333 ± 133 | 212 ± 112 | <0.001 |
Duration of stimulation (day)a | 11.5 ± 2.3 | 11.8 ± 2.4 | 0.58 |
Number of follicles 11–15 mma | 3.2 ± 2.8 | 4.6 ± 3.3 | 0.009 |
Number of follicles>15 mma | 5.2 ± 2.8 | 6.5 ± 2.7 | 0.006 |
Number of oocyte retrieveda | 5.7 ± 4.0 | 7.2 ± 3.6 | 0.024 |
Number of oocyte useda,b | 2.8 ± 2.3 | 3.8 ± 2.7 | 0.034 |
Number of embryos obtaineda,b | 2.0 ± 1.9 | 2.8 ± 2.0 | 0.024 |
Number of transfers not performeda | 14 (28%) | 16 (15%) | 0.08 |
Number of embryos transferredc | 2.0 ± 0.6 | 2.2 ± 0.7 | 0.20 |
Clinical pregnancy rate (PR) | |||
Number of pregnancies | 5 | 26 | |
PR per starting cycle | 7% | 19% | 0.037 |
PR per oocyte retrieval | 10% | 24% | 0.051 |
PR per embryo transfer | 14% | 28% | 0.11 |
Implantation rate | 5 (7%) | 33 (16%) | 0.048 |
Delivery rate (DR) | |||
Number of deliveries | 3 | 23 | |
DR per starting cycle | 4% | 17% | 0.013 |
DR per oocyte retrieval | 6% | 21% | 0.02 |
DR per embryo transfer | 8% | 25% | 0.049 |
- aData refer to patients undergoing oocyte retrieval.
- bThe number of oocytes retrieved and oocytes used differ due to the new Italian legislation that since March 2004 bans the use of more than three oocytes.
- cData refer to patients performing embryo transfer.
沒有留言:
張貼留言